Gilead Sciences, Inc (GILD) Gilead Receives All Required Regulatory Approvals for the Acquisition of Arcellx and Extends Tender Offer

Gilead Sciences, Inc (NASDAQ: GILD) FY 2026 Other Release

Newsdesk: